arBtrage CAPITALIZING MARKETS checking… Sign in

Intellia Therapeutics, Inc.

NTLA Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$13.54
▼ -8.2% Today
as of Jun 7, 07:23 ET
Last 30 days +2.58% Apr 28 → Jun 05
$11.72 $12.53 $13.34 $14.16 $14.97 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$14.50
High
$14.79
Low
$12.89
Volume
$7M
Avg Vol
$6M
Mkt Cap
$1.9B
P/E (TTM)
Beta
52w High
$28.25
52w Low
$7.31
Div Yield
Shares Out
$120M

Overview

52-week range
$7.31
$28
30% of range
Avg surprise (last 2)
+12.3%
Avg reaction (last 2)
+8.0%
100% positive
Latest IV / EM
127%
EM ±17.5% · $14 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.52$-1.34$-1.17$-0.99$-0.81 Actual $-1.40Actual $-1.38Actual $-1.12Actual $-1.52Actual $-1.34Actual $-1.10Est $-1.26Actual $-0.98Actual $-0.92Actual $-0.81Est $-0.92 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-147M$-106M$-65M$-24M$17M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.81 $-0.92 +12.0% +26.4% +2.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.92 financials
Mon Jun 30, 2025Jun 2025 $-0.98 financials
Thu May 8, 2025Mar/2025 $-1.10 $-1.26 +12.7% +13.6% earnings
Mon Sep 30, 2024Sep 2024 $-1.34 financials
Sun Jun 30, 2024Jun 2024 $-1.52 financials
Sun Mar 31, 2024Mar 2024 $-1.12 financials
Sat Sep 30, 2023Sep 2023 $-1.38 financials
Fri Jun 30, 2023Jun 2023 $-1.40 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$15M$14M$14M$17M$9M$7M
Cost of revenue
Gross profit
Operating income$-101M$-111M$-110M$-121M$-145M$-139M
Net income$-96M$-101M$-101M$-114M$-136M$-147M
EPS (diluted)$-0.81$-0.92$-0.98$-1.10$-1.34$-1.52

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$135M$155M$193M$156M$127M$189M$120M$131M
Inventory
Total current assets$466M$528M$582M$496M$551M$640M$711M$757M
Total assets$759M$842M$925M$899M$986M$1.19B$1.17B$1.19B
Long-term debt
Total liabilities$138M$171M$177M$184M$206M$319M$211M$220M
Total equity$621M$671M$748M$715M$780M$872M$963M$971M

Implied volatility — last 90 days

121%124%126%129%131% Jun 07 — IV 127% · EM ±17.5%

Sector peers